Neuronetics Inc STIM.OQ STIM.O is expected to show a rise in quarterly revenue when it reports results on August 5 for the period ending June 30 2025
The Malvern Pennsylvania-based company is expected to report a 123.7% increase in revenue to $36.8 million from $16.45 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on May 6 2025, for the period ended June 30, was for revenue between $36.00 million and $38.00 million.
LSEG's mean analyst estimate for Neuronetics Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Neuronetics Inc is $7.00, about 37.3% above its last closing price of $4.39
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.13
-0.12
-0.21
Missed
-68
Dec. 31 2025
-0.25
-0.21
-0.33
Missed
-57.1
Sep. 30 2024
-0.23
-0.23
-0.44
Missed
-91.3
Jun. 30 2024
-0.27
-0.27
-0.33
Missed
-22.2
Mar. 31 2024
-0.32
-0.31
-0.27
Beat
12.9
Dec. 31 2023
-0.26
-0.26
-0.19
Beat
27.3
Sep. 30 2023
-0.31
-0.31
-0.33
Missed
-6.7
Jun. 30 2023
-0.35
-0.35
-0.17
Beat
51.2
This summary was machine generated August 1 at 13:10 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)